Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice
- 31 May 1995
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 25 (6), 1327-1332
- https://doi.org/10.1016/0735-1097(94)00552-2
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- β-Blocker therapy in acute myocardial infarction: Evidence for underutilization in the elderlyAmerican Journal Of Medicine, 1992
- Cumulative Meta-Analysis of Therapeutic Trials for Myocardial InfarctionThe New England Journal of Medicine, 1992
- Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group.Circulation, 1992
- Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failureJournal of the American College of Cardiology, 1990
- Prognosis and Management after a First Myocardial InfarctionThe New England Journal of Medicine, 1990
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionThe New England Journal of Medicine, 1988
- The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patientsEuropean Heart Journal, 1988
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJama-Journal Of The American Medical Association, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionThe New England Journal of Medicine, 1981